A detailed history of Passumpsic Savings Bank transactions in Novo Nordisk A S stock. As of the latest transaction made, Passumpsic Savings Bank holds 21,448 shares of NVO stock, worth $2.33 Million. This represents 1.68% of its overall portfolio holdings.

Number of Shares
21,448
Previous 21,254 0.91%
Holding current value
$2.33 Million
Previous $3.03 Billion 15.82%
% of portfolio
1.68%
Previous 2.18%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$119.07 - $145.42 $23,099 - $28,211
194 Added 0.91%
21,448 $2.55 Billion
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $527,407 - $631,419
-4,298 Reduced 16.82%
21,254 $3.03 Billion
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $2.61 Million - $3.47 Million
25,552 New
25,552 $3.28 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $245B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Passumpsic Savings Bank Portfolio

Follow Passumpsic Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Passumpsic Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Passumpsic Savings Bank with notifications on news.